REIT - Office
Compare Stocks
2 / 10Stock Comparison
NYC vs WELL
Revenue, margins, valuation, and 5-year total return — side by side.
REIT - Healthcare Facilities
NYC vs WELL — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||
|---|---|---|
| Industry | REIT - Office | REIT - Healthcare Facilities |
| Market Cap | $20M | $149.25B |
| Revenue (TTM) | $39M | $11.63B |
| Net Income (TTM) | $-21M | $1.43B |
| Gross Margin | 6.2% | 39.1% |
| Operating Margin | -168.6% | 4.4% |
| Forward P/E | — | 78.4x |
| Total Debt | $403M | $21.38B |
| Cash & Equiv. | $10M | $5.03B |
NYC vs WELL — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Aug 20 | May 26 | Return |
|---|---|---|---|
| American Strategic … (NYC) | 100 | 7.6 | -92.4% |
| Welltower Inc. (WELL) | 100 | 370.3 | +270.3% |
Price return only. Dividends and distributions are not included.
Quick Verdict: NYC vs WELL
Each card shows where this stock fits in a portfolio — not just who wins on paper.
In this particular matchup, NYC is outpaced on most metrics by others in the set.
WELL carries the broadest edge in this set and is the clearest fit for income & stability and growth exposure.
- Dividend streak 2 yrs, beta 0.13, yield 1.3%
- Rev growth 35.8%, EPS growth -11.5%, 3Y rev CAGR 22.7%
- 223.1% 10Y total return vs NYC's -93.8%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 35.8% FFO/revenue growth vs NYC's -1.8% | |
| Quality / Margins | 12.3% margin vs NYC's -53.6% | |
| Stability / Safety | Lower D/E ratio (49.5% vs 471.0%) | |
| Dividends | 1.3% yield; 2-year raise streak; the other pay no meaningful dividend | |
| Momentum (1Y) | +42.7% vs NYC's -30.7% | |
| Efficiency (ROA) | 2.3% ROA vs NYC's -4.7%, ROIC 0.5% vs -15.8% |
NYC vs WELL — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
NYC vs WELL — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
WELL leads this category, winning 5 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
WELL is the larger business by revenue, generating $11.6B annually — 295.0x NYC's $39M. WELL is the more profitable business, keeping 12.3% of every revenue dollar as net income compared to NYC's -53.6%. On growth, WELL holds the edge at +40.3% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||
|---|---|---|
| RevenueTrailing 12 months | $39M | $11.6B |
| EBITDAEarnings before interest/tax | -$53M | $2.8B |
| Net IncomeAfter-tax profit | -$21M | $1.4B |
| Free Cash FlowCash after capex | -$13M | $2.5B |
| Gross MarginGross profit ÷ Revenue | +6.2% | +39.1% |
| Operating MarginEBIT ÷ Revenue | -168.6% | +4.4% |
| Net MarginNet income ÷ Revenue | -53.6% | +12.3% |
| FCF MarginFCF ÷ Revenue | -33.4% | +21.9% |
| Rev. Growth (YoY)Latest quarter vs prior year | -100.0% | +40.3% |
| EPS Growth (YoY)Latest quarter vs prior year | +2.0% | +22.5% |
Valuation Metrics
NYC leads this category, winning 3 of 3 comparable metrics.
Valuation Metrics
| Metric | ||
|---|---|---|
| Market CapShares × price | $20M | $149.2B |
| Enterprise ValueMkt cap + debt − cash | $413M | $165.6B |
| Trailing P/EPrice ÷ TTM EPS | -0.14x | 153.25x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 78.42x |
| PEG RatioP/E ÷ EPS growth rate | — | — |
| EV / EBITDAEnterprise value multiple | — | 66.40x |
| Price / SalesMarket cap ÷ Revenue | 0.33x | 13.99x |
| Price / BookPrice ÷ Book value/share | 0.23x | 3.35x |
| Price / FCFMarket cap ÷ FCF | — | 52.41x |
Profitability & Efficiency
WELL leads this category, winning 7 of 9 comparable metrics.
Profitability & Efficiency
WELL delivers a 3.5% return on equity — every $100 of shareholder capital generates $3 in annual profit, vs $-30 for NYC. WELL carries lower financial leverage with a 0.49x debt-to-equity ratio, signaling a more conservative balance sheet compared to NYC's 4.71x. On the Piotroski fundamental quality scale (0–9), WELL scores 7/9 vs NYC's 2/9, reflecting strong financial health.
| Metric | ||
|---|---|---|
| ROE (TTM)Return on equity | -29.6% | +3.5% |
| ROA (TTM)Return on assets | -4.7% | +2.3% |
| ROICReturn on invested capital | -15.8% | +0.5% |
| ROCEReturn on capital employed | -20.8% | +0.6% |
| Piotroski ScoreFundamental quality 0–9 | 2 | 7 |
| Debt / EquityFinancial leverage | 4.71x | 0.49x |
| Net DebtTotal debt minus cash | $393M | $16.3B |
| Cash & Equiv.Liquid assets | $10M | $5.0B |
| Total DebtShort + long-term debt | $403M | $21.4B |
| Interest CoverageEBIT ÷ Interest expense | -6.22x | 0.26x |
Total Returns (Dividends Reinvested)
WELL leads this category, winning 6 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in WELL five years ago would be worth $30,234 today (with dividends reinvested), compared to $1,191 for NYC. Over the past 12 months, WELL leads with a +42.7% total return vs NYC's -30.7%. The 3-year compound annual growth rate (CAGR) favors WELL at 42.5% vs NYC's -2.1% — a key indicator of consistent wealth creation.
| Metric | ||
|---|---|---|
| YTD ReturnYear-to-date | -6.0% | +14.3% |
| 1-Year ReturnPast 12 months | -30.7% | +42.7% |
| 3-Year ReturnCumulative with dividends | -6.0% | +189.5% |
| 5-Year ReturnCumulative with dividends | -88.1% | +202.3% |
| 10-Year ReturnCumulative with dividends | -93.8% | +223.1% |
| CAGR (3Y)Annualised 3-year return | -2.1% | +42.5% |
Risk & Volatility
Evenly matched — NYC and WELL each lead in 1 of 2 comparable metrics.
Risk & Volatility
NYC is the less volatile stock with a -0.26 beta — it tends to amplify market swings less than WELL's 0.13 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. WELL currently trades 97.0% from its 52-week high vs NYC's 49.6% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | -0.26x | 0.13x |
| 52-Week HighHighest price in past year | $16.30 | $219.59 |
| 52-Week LowLowest price in past year | $7.03 | $142.65 |
| % of 52W HighCurrent price vs 52-week peak | +49.6% | +97.0% |
| RSI (14)Momentum oscillator 0–100 | 49.2 | 60.2 |
| Avg Volume (50D)Average daily shares traded | 2K | 2.6M |
Analyst Outlook
WELL leads this category, winning 1 of 1 comparable metric.
Analyst Outlook
WELL is the only dividend payer here at 1.30% yield — a key consideration for income-focused portfolios.
| Metric | ||
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | Buy |
| Price TargetConsensus 12-month target | — | $226.50 |
| # AnalystsCovering analysts | — | 34 |
| Dividend YieldAnnual dividend ÷ price | — | +1.3% |
| Dividend StreakConsecutive years of raises | 0 | 2 |
| Dividend / ShareAnnual DPS | — | $2.76 |
| Buyback YieldShare repurchases ÷ mkt cap | +1.1% | 0.0% |
WELL leads in 4 of 6 categories (Income & Cash Flow, Profitability & Efficiency). NYC leads in 1 (Valuation Metrics). 1 tied.
NYC vs WELL: Frequently Asked Questions
8 questions · data-driven answers · updated daily
01Is NYC or WELL a better buy right now?
For growth investors, Welltower Inc.
(WELL) is the stronger pick with 35. 8% revenue growth year-over-year, versus -1. 8% for American Strategic Investment Co. (NYC). Welltower Inc. (WELL) offers the better valuation at 153. 3x trailing P/E (78. 4x forward), making it the more compelling value choice. Analysts rate Welltower Inc. (WELL) a "Buy" — based on 34 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which is the better long-term investment — NYC or WELL?
Over the past 5 years, Welltower Inc.
(WELL) delivered a total return of +202. 3%, compared to -88. 1% for American Strategic Investment Co. (NYC). Over 10 years, the gap is even starker: WELL returned +223. 1% versus NYC's -93. 8%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
03Which is safer — NYC or WELL?
By beta (market sensitivity over 5 years), American Strategic Investment Co.
(NYC) is the lower-risk stock at -0. 26β versus Welltower Inc. 's 0. 13β — meaning WELL is approximately -150% more volatile than NYC relative to the S&P 500. On balance sheet safety, Welltower Inc. (WELL) carries a lower debt/equity ratio of 49% versus 5% for American Strategic Investment Co. — giving it more financial flexibility in a downturn.
04Which is growing faster — NYC or WELL?
By revenue growth (latest reported year), Welltower Inc.
(WELL) is pulling ahead at 35. 8% versus -1. 8% for American Strategic Investment Co. (NYC). On earnings-per-share growth, the picture is similar: Welltower Inc. grew EPS -11. 5% year-over-year, compared to -18. 8% for American Strategic Investment Co.. Over a 3-year CAGR, WELL leads at 22. 7% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
05Which has better profit margins — NYC or WELL?
Welltower Inc.
(WELL) is the more profitable company, earning 8. 8% net margin versus -228. 3% for American Strategic Investment Co. — meaning it keeps 8. 8% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: WELL leads at 3. 3% versus -196. 9% for NYC. At the gross margin level — before operating expenses — WELL leads at 39. 2%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
06Which pays a better dividend — NYC or WELL?
In this comparison, WELL (1.
3% yield) pays a dividend. NYC does not pay a meaningful dividend and should not be held primarily for income.
07Is NYC or WELL better for a retirement portfolio?
For long-horizon retirement investors, Welltower Inc.
(WELL) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 13), 1. 3% yield, +223. 1% 10Y return). Both have compounded well over 10 years (WELL: +223. 1%, NYC: -93. 8%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
08What are the main differences between NYC and WELL?
Both stocks operate in the Real Estate sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: NYC is a small-cap quality compounder stock; WELL is a mid-cap high-growth stock. WELL pays a dividend while NYC does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.